Dyslipoproteinemia and Peripheral Arterial Occlusive Disease

Angiology

Volumn 55, Issue 2, 2004, Pages 135-138

  Kröger, Knut ^a,b  

^a University Hospital Essen ^*

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOPROTEIN;

ARTICLE; CARDIOVASCULAR RISK; DISEASE ASSOCIATION; DYSLIPOPROTEINEMIA; HEART INFARCTION; HUMAN; PERIPHERAL OCCLUSIVE ARTERY DISEASE; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; STROKE;

ARTERIAL OCCLUSIVE DISEASES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERLIPOPROTEINEMIAS; PERIPHERAL VASCULAR DISEASES;

EID: 1542619557     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: 10.1177/000331970405500204     Document Type: Article

References (24)

1. Heart Protection Study Collaborative Group: MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: A randomised placebo controlled trial. Lancet 360:7-22, 2002.
2. Herbert PR, Gaziano JM, Chan KS, et al: Cholesterol lowering with statin drugs, risk of stroke and total mortality. JAMA 287:313-321, 1997.
3. Fayad ZA, Fuster V: Clinical imaging of the high-risk or vulnerable atherosclerotic plaque. Circ Res 89: 305-316, 2001.
4. Hooi JD, Kester AD, Stoffers HE, et al: Incidence of and risk factors for asymptomatic peripheral arterial occlusive disease: A longitudinal study. Am J Epidemiol 153:666-672, 2001.
5. Dormandy J, Heeck L, Vig S: Acute limb ischemia. Semin Vasc Surg 12:148-153, 1999.
6. CAPRIE Steering Committee: A randomised, blinded trial of Clopidogrel versus aspirin in patients at risk of ischemic events (CAPRIE). Lancet 348:1329-1339, 1996.
7. Binaghi F, Fronteddu PF, Cannas F, et al: Prevalence of peripheral arterial occlusive disease and associated risk factors in a sample of southern Sardinian population. Int Angiol 13:233-245, 1994.
8. Drexel H, Steuer J, Muntwyler J, et al: Predictors of the presence and extent of peripheral arterial occlusive disease. Circulation 94:199-205, 1996.
9. Buchwald H, Varco RL, Matts JP, et al: Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia. N Engl J Med 323:946-955, 1990.
10. Blankenhorn DH, Azen SP, Crawford DW, et al: Effects of colestipol-niacin therapy on human femoral atherosclerosis. Circulation 83:438-447, 1991.
11. Pedersen TR, Kjekshus J, Pyörälä K, et al: Effect of simvastatin on ischemic signs and symptoms in the Scandinavian simvastatin survival study. Am J Cardiol 81:333-335, 1998.
12. Salonen R, Nyyssonen K, Porkkala E, et al: Kuopio atherosclerosis prevention study (KAPS). Circulation 92:1758-1764, 1995.
13. Youssef F, Seifalian AM, Jagroop IA, et al: The early effect of lipid-lowering treatment on carotid and femoral intima media thickness (IMT). Eur J Vasc Endovasc Surg 23:358-364, 2002.
14. McDermott MM, Guralnik JM, Greenland P, et al: Statin use and leg functioning in patients with and without lower-extremity peripheral arterial disease. Circulation 107:757-761, 2003.
15. Dormandy J, Heek L, Vig S: Predictors of early disease in the lower limbs. Semin Vasc Surg 12:109-117, 1999.
16. Clement DL: Medical treatment of peripheral artery occlusive disease. Acta Chir Belg 100:190-193, 2000.
17. National Cholesterol Education Program Expert Panel: Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 285:2486-2497, 2001.
18. Aronow WS, Ahn C: Frequency of new coronary events in older persons with peripheral arterial disease and serum low-density lipoprotein cholesterol > or = 125 mg/dL treated with statins versus no lipid-lowering drug. Am J Cardiol 90:789-791, 2002.
19. Meade T, Zuhrie R, Cook C, et al: Bezafibrate in men with lower extremity arterial disease: Randomised controlled trial. BMJ 325:1139-1143, 2002.
20. Meijer WT, Hoes AW, Rutgers D, et al: Peripheral arterial disease in the elderly. The Rotterdam Study. Arterioscler Thromb Vasc Biol 18:185-192, 1998.
21. Ness J, Aronow WS, Ahn C: Risk factors for symptomatic peripheral arterial disease in older persons in an academic hospital-based geriatrics practice. J Am Geriatr Soc 48:312-314, 2000.
22. Athyros VG, Papageorgiou AA, Elisaf M, et al: Statins and renal function in patients with diabetes mellitus. Curr Med Res Opin 19:615-617, 2003.
23. Elisaf M, Mikhailidis DP: Statins and renal function. Angiology 53:493-502, 2002.
24. Antignani PL: Treatment of chronic peripheral arterial disease. Curr Vasc Pharmacol 1:205-216, 2003.